Fears of a link between testosterone replacement therapy and cardiovascular risk are misplaced, shows a review published in this month's iMayo Clinic Proceedings/i. The therapy has come under widespread scrutiny in recent months, including by a federal Food and Drug Administration (FDA) panel convened last fall. "There's no good evidence that we could find that testosterone therapy increases cardiovascular risk," says lead author Abraham Morgentaler, ...
No comments:
Post a Comment